Histone Methylation, Energy Metabolism, and Alzheimer's Disease
- PMID: 39656495
- PMCID: PMC12339095
- DOI: 10.14336/AD.2024.0899
Histone Methylation, Energy Metabolism, and Alzheimer's Disease
Abstract
Alzheimer's disease (AD) is an insidious, progressive, and irreversible neurodegenerative disease characterized by the deposition of extracellular amyloid β-protein (Aβ) to form senile plaques and abnormal phosphorylation of intracellular tau protein to form neuronal fiber tangles. The pathogenesis of AD is complex, and there are several hypotheses, primarily including the Aβ cascade hypothesis, the neurofibrillary tangle hypothesis, the inflammatory hypothesis, and the cholinergic hypothesis. It has been suggested that the dysregulation of multiple energy metabolic pathways, especially mitochondria metabolism, may be related to the severity of AD pathology and disease symptoms in the brain. The modification of histone (lysine) methylation, an actively regulated and reversible process, is closely related to energy metabolism and plays a crucial role in AD development. In summary, histone methylation, energy metabolism, and AD restricted and regulated each other. Here, we review the advances in the correlation between histone methylation, energy metabolism, and AD. This can provide further insights into the mechanisms underlying AD pathogenesis and its control.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Neuron-Derived Extracellular Vesicles: Emerging Biomarkers and Functional Mediators in Alzheimer's Disease, With Comparative Insights Into Neurodevelopment and Aging.Dev Neurobiol. 2025 Jul;85(3):e22984. doi: 10.1002/dneu.22984. Dev Neurobiol. 2025. PMID: 40503760 Free PMC article. Review.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
NRN1 may Modulate Tau Phosphorylation and Neuronal Apoptosis in AD via the PIGU-CASP3 Axis.Curr Alzheimer Res. 2025;22(3):219-231. doi: 10.2174/0115672050361366250328040542. Curr Alzheimer Res. 2025. PMID: 40296620
-
C/EBPβ: A transcription factor associated with the irreversible progression of Alzheimer's disease.CNS Neurosci Ther. 2024 Apr;30(4):e14721. doi: 10.1111/cns.14721. CNS Neurosci Ther. 2024. PMID: 38644578 Free PMC article.
Cited by
-
Biomolecular Aspects of Reelin in Neurodegenerative Disorders: An Old Candidate for a New Linkage of the Gut-Brain-Eye Axis.Int J Mol Sci. 2025 Jul 30;26(15):7352. doi: 10.3390/ijms26157352. Int J Mol Sci. 2025. PMID: 40806482 Free PMC article. Review.
References
-
- Rosario ER, Chang L, Stanczyk FZ, Pike CJ (2004). Age-related testosterone depletion and the development of Alzheimer disease. Jama, 292:1431-1432. - PubMed
-
- Migliore L, Coppedè F (2022). Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics. Nat Rev Neurol, 18:643-660. - PubMed
-
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2023). Hallmarks of aging: An expanding universe. Cell, 186:243-278. - PubMed
-
- Millán-Zambrano G, Burton A, Bannister AJ, Schneider R (2022). Histone post-translational modifications - cause and consequence of genome function. Nat Rev Genet, 23:563-580. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical